5 March 2010, 5:00 am
SALT LAKE CITY, UT--(Marketwire - 03/05/10) - Paradigm Medical Industries, Inc. (Pinksheets: PDMI - News ) announced today that it has been notified by its Italian partner, Costruzione Strumenti Oftalmici (CSO), that all necessary documents have been completed and submitted to the United States Food and Drug Administration (FDA) for the Retimax, also known as the Paramax. Paradigm is the ...... Read More »